$142 Million is the total value of Foresite Capital Management I, LLC's 11 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | $48,984,000 | +50.2% | 1,585,743 | 0.0% | 34.41% | +8.6% | |
| KERX | Keryx Biopharmaceuticals Inc. | $22,357,000 | +31.6% | 1,312,006 | 0.0% | 15.70% | -4.8% | |
| AMBI | Ambit Biosciences Corporation | $18,966,000 | -5.4% | 2,079,569 | 0.0% | 13.32% | -31.6% | |
| ACRX | ACELRX Pharmaceuticals, Inc. | $16,563,000 | +6.2% | 1,379,080 | 0.0% | 11.64% | -23.2% | |
| XNCR | Xencor, Inc. | $9,619,000 | +28.3% | 820,000 | 0.0% | 6.76% | -7.2% | |
| OREX | New | Orexigen Therapeutics, Inc. | $8,125,000 | – | 1,250,000 | +100.0% | 5.71% | – |
| NVAX | Novavax Inc. | $6,053,000 | -11.5% | 1,336,200 | 0.0% | 4.25% | -36.0% | |
| BDSI | New | BioDelivery Sciences International, Inc. | $5,908,000 | – | 700,000 | +100.0% | 4.15% | – |
| RXDX | New | Ignyta, Inc. | $4,150,000 | – | 500,000 | +100.0% | 2.92% | – |
| NVAX | Sell | Novavax Inc.put | $906,000 | +5562.5% | 2,000 | -69.3% | 0.64% | +3875.0% |
| XLRN | Sell | Acceleron Pharma Inc. | $721,000 | -72.4% | 20,892 | -68.3% | 0.51% | -80.1% |
| BDSI | Exit | BioDelivery Sciences International, Inc.call | $0 | – | -2,000 | -100.0% | -0.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc. | 16 | Q3 2021 | 43.0% |
| 10X Genomics, Inc. | 12 | Q3 2022 | 100.0% |
| Epizyme, Inc. | 8 | Q1 2022 | 1.7% |
| Orexigen Therapeutics, Inc. | 7 | Q3 2015 | 44.3% |
| BioDelivery Sciences International, Inc. | 7 | Q3 2015 | 29.3% |
| Karyopharm Therapeutics Inc. | 5 | Q4 2014 | 55.1% |
| Xencor, Inc. | 5 | Q4 2014 | 13.8% |
| Novavax, Inc. | 5 | Q3 2021 | 10.8% |
| Ignyta, Inc. | 5 | Q1 2015 | 15.4% |
| Ambit Biosciences Corporation | 4 | Q3 2014 | 30.7% |
View Foresite Capital Management I, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-13 |
View Foresite Capital Management I, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.